Variability in the Relationship between Mean Plasma Glucose and HbA1c: Implications for the Assessment of Glycemic Control
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Previous studies have shown a single linear relationship between mean plasma glucose (MPG) and hemoglobin A1c (HbA1c). We examined the relationship in different treatment groups of patients with type 1 diabetes participating in the Diabetes Control and Complications Trial (DCCT). Methods: Seven-point glucose profiles (premeal, postmeal, and bedtime) and HbA1c were measured quarterly during the DCCT. We studied measurements from (a) intensively treated patients at study commencement, (b) intensively treated patients after stabilization of their glycemia (from 6 months onward), and (c) conventionally treated patients from 6 months onward. Only complete glucose profile and HbA1c pairings were considered (n = 589, 11 483, and 11 855, respectively). Results: From 6 months into the trial, conventionally treated patients had consistently higher MPG concentrations than intensively treated patients at any given HbA1c value (mean difference, 1.6 mmol/L at 7% HbA1c, increasing to 2.8 mmol/L at 11% HbA1c). Similarly, at the same HbA1c, the MPG of intensively treated patients at baseline was higher than in the same individuals after 6 months of intensive treatment (1.2 mmol/L difference at 7% HbA1c, increasing to 4.6 mmol/L at 11% HbA1c). Conclusions: The relationship between MPG and HbA1c is not constant but differs depending on the glycemic control of the population being studied. Having lower mean glucose at the same HbA1c may help explain why intensive DCCT treatment appeared intrinsically linked to both increased hypoglycemia and decreased microvascular complications compared with conventional treatment. These findings may also have implications for expressing HbA1c as mean blood glucose equivalent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diabetes Control and Complications Trial Research Group (1995) · Diabetes · doi:10.2337/diab.44.8.968 · Cited by 1,301
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945 · cited 1×
“Increased glucose variability in the latter group has been postulated as the cause ( 20 ), although a recent analysis of DCCT data seems to discount this as a possibility (21).”
BackgroundSteffes, M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.042143 · Cited by 125 · cited 1×
“HbA1c samples were express-transported at 4 °C to the Central HbA1c Laboratory, where samples were originally analyzed on a HPLC column (Biorex 70; Bio-Rad); within- and betweenassay CVs for this HbA1c method were 6%. From November 1986 onward, a Diamat HPLC instrument (Bio-Rad) was used, with which both CVs were cons…”
Method
Cited by
Lachin, J. M., Genuth, S., Nathan, D. M., Zinman, B., Rutledge, B. N., & for the DCCT/EDIC Research Group (2008) · Diabetes · doi:10.2337/db07-1618 · Cited by 555
Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
Cohen, R. M., Franco, R. S., Khera, P. K., Smith, E. P., Lindsell, C. J., Ciraolo, P. J., Palascak, M. B., & Joiner, C. H. (2008) · Blood · doi:10.1182/blood-2008-04-154112 · Cited by 478
The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes
Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L. (2008) · Diabetes Care · doi:10.2337/dc08-0864 · Cited by 420
Self-citationGlucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels
Bergenstal, R. M., Gal, R. L., Connor, C. G., Gubitosi-Klug, R., Kruger, D., Olson, B. A., Willi, S. M., Aleppo, G., Weinstock, R. S., Wood, J., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2596 · Cited by 306
Review of hemoglobin A1c in the management of diabetes
GALLAGHER, E. J., LE ROITH, D., & BLOOMGARDEN, Z. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00009.x · Cited by 304
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009122.pub2 · Cited by 299
Relationship Between A1C and Glucose Levels in the General Dutch Population
van 't Riet, E., Alssema, M., Rijkelijkhuizen, J. M., Kostense, P. J., Nijpels, G., & Dekker, J. M. (2010) · Diabetes Care · doi:10.2337/dc09-0677 · Cited by 199
“(23) showed in the DCCT that for any given A1C, the plasma glucose levels of participants in different treatment groups were not the same.”
Acute hyperglycemia and oxidative stress: Direct cause and effect?
Choi, S.-W., Benzie, I. F. F., Ma, S.-W., Strain, J. J., & Hannigan, B. M. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.005 · Cited by 149
Wu, J.-D., Xu, X.-H., Zhu, J., Ding, B., Du, T.-X., Gao, G., Mao, X.-M., Ye, L., Lee, K.-O., & Ma, J.-H. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0048 · Cited by 89
Randløv, J., & Poulsen, J. U. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200209 · Cited by 61
Inpatient HbA1c testing: a prospective observational study
Nanayakkara, N., Nguyen, H., Churilov, L., Kong, A., Pang, N., Hart, G. K., Owen-Jones, E., White, J., Ross, J., Stevenson, V., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000113 · Cited by 43
Metadata
- Authors
- Kilpatrick, E. S., Rigby, A. S., & Atkin, S. L.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-01
- Volume
- 53
- Issue
- 5
- Pages
- 897-901
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2105677350
- Cited by
- 96
- References
- 3
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.